The first patient in the landmark Pilot Investigation of Stem Cells in Stroke (PISCES) trial has been treated with neural stem cells. The study is the first fully regulated clinical trial of neural stem cell therapy for stroke. Investigators will evaluate the safety of ReNeuron cells in disabled ischemic stroke patients.
This is a first in man safety study, lead investigator Keith Muir, MD, from the University of Glasgows Institute of Neuroscience and Psychology in Scotland, explained to Medscape Medical News. We are looking at neurological effects clinical and imaging only as secondary goals.
The stem cells are from a genetically modified immortalized cell line derived from a tissue sample from 12-week fetal cortex.
Critics of stem cell development generally have various reasons for their ethical objections, Dr. Muir said. For most, it relates to embryo use not relevant in this case, he argues. Others might object to termination of pregnancy, but these cells are derived from material donated to a tissue bank from a single legal termination many years ago, which was done for social reasons and was unrelated to the subsequent use.
This study was approved by the United Kingdom Medicines and Healthcare Products Regulatory Agency. ReNeuron is the first company to receive regulatory approval for any stem cellbased clinical trial in the United Kingdom.
PISCES Trial
The first patient in this pilot investigation was treated in Glasgow. The male patient was injected with cells to the affected region of the brain and has since been discharged from the hospital. He will be monitored closely for 2 years with longer-term follow-up procedures afterward.
Investigators are still recruiting for the trial and plan for 12 patients to take part. They will be given the ReN001 therapy between 6 and 24 months after stroke.
PISCES is an open-label study with no control group. We feel this is an appropriate design for a first in man study, Dr. Muir said, and we are not seeking to draw conclusions about efficacy at this stage.
Trial investigators suggest that because of the nature of the procedure and the characteristics of the stem cells, immunosuppression will not be necessary for patients taking part in the study. This, they say, will eliminate the safety risks typically associated with immunosuppression regimens.
Continue reading here:
First Stroke Patient Treated With Neural Stem Cell Therapy
- GeneTether Therapeutics Publishes Paper on Novel Recombination Products in the CFTR Gene - TheNewswire.ca - May 15th, 2022
- Procreating Robots: The Next Big Thing In Cognitive Automation? - Forbes - May 2nd, 2022
- A juicy tomato this summer begins with starting sturdy transplants now. - Vermont Public Radio - April 6th, 2022
- Hard Time: Vermont Hasn't Lost a Single Prisoner to COVID-19. But at What Cost? - Seven Days - March 25th, 2022
- Why the worlds first organic robots are amphibian, African, and smart; By Okezue Bell - SundiataPost - November 22nd, 2021
- The University of Vermont: Impactful research, healthier world - Study International News - July 21st, 2021
- Team Builds the First Living Robots - University of Vermont - June 20th, 2020
- 2019 Stem Cell Conference- Lung Biology, Continuing ... - May 10th, 2020
- Stem Cell therapy Gilman Vermont 05904 - April 16th, 2020
- Scientists Have Created Living Robot Frogs, And They Just May Save Your Life - Parentology - January 28th, 2020
- World's First 'Living Machine' Created Using Frog Cells and Artificial Intelligence - Livescience.com - January 18th, 2020
- Scientists Move Us One Step Closer To A Real-Life Westworld As They Create Robots From Living Cells - BroBible - January 18th, 2020
- US troops were injured in Iran's Jan. 8 attack; Army cancels $45B vehicle competition; Riyadh gives US $0.5B for ops; Navy adding drone controllers to... - January 18th, 2020
- The Democratic Debates Are Downers. That's a Big Problem for All of Us. - Reason - January 18th, 2020
- Stem Cell - Lung Biology | College of Medicine ... - May 13th, 2019
- Women Can Do - Women & Girls in STEM | Women Empowerment - March 6th, 2019
- Stem Cell Therapy Vermont - Cordblood Search Tools - November 13th, 2018
- Stem Cell Centers - Williston > Stem Cell Centers - November 13th, 2018
- Stem Cells Conference - Continuing Medical Education ... - July 16th, 2018
- Volunteer Scientists in DC-metro schools | Reset Online - June 19th, 2018
- Continuing the debate about right-to-die issues in Appleton - Wichita Eagle - September 6th, 2017
- Year after Jerika Bolen's death, debate continues on right-to-die issues - USA TODAY - August 28th, 2017
- Mark Blazis: Mushroom hunting a delicious endeavor - Worcester Telegram - August 28th, 2017
- Shoulder Stem Cell and Platelet Treatments - Vermont ... - August 23rd, 2017
- S Muoio & Company Has Raised Its Clarcor (CLC) Position; Biolife Solutions (BLFS) Shorts Raised By 7.43% - HuronReport - August 23rd, 2017
- FreshTracks Capital invests in Ogee - vtdigger.org - July 12th, 2017
- Regenexx Stem Cell & Platelet Procedures - Vermont ... - November 23rd, 2016
- Knee Stem Cell Therapy - Vermont Regenerative Medicine - August 6th, 2016
- Home - Vermont Regenerative Medicine - October 19th, 2015
- Developers expect to break ground on NEK biotech plant in May - April 7th, 2015
- Australasian Society for Stem Cell Research The ... - March 7th, 2015
- Stem Cells Cure Blindness | Serendip Studio - January 14th, 2015
- Stem Cell Research Poll Results - iSideWith - November 26th, 2014
- Concise Review: Current Status of Stem Cells and ... - November 5th, 2014
- PROCHYMAL (Human Adult Stem Cells) for the Treatment of ... - October 16th, 2014
- Stem Cell Research | Parkinson's Action Network - September 27th, 2014
- Vermont Stem Cell Treatments | Stem Cell Treatments - September 5th, 2014
- The Vermont Cancer Center's Stem Cell Transplant Program ... - August 24th, 2014